V.K. Chiu

479 total citations
9 papers, 187 citations indexed

About

V.K. Chiu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, V.K. Chiu has authored 9 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in V.K. Chiu's work include Cancer therapeutics and mechanisms (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). V.K. Chiu is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). V.K. Chiu collaborates with scholars based in United States, Spain and China. V.K. Chiu's co-authors include William R. Clark, Craig M. Walsh, Alison A. Glass, John C. Reed, Adriana Gregory, Wahid T. Hanna, Ahmed N. Abdalla, Nehal J. Lakhani, Rajesh Malik and Mohamad Bassam Sonbol and has published in prestigious journals such as The Journal of Immunology, Annals of Oncology and ESMO Open.

In The Last Decade

V.K. Chiu

7 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V.K. Chiu United States	3	119	112	31	23	15	9	187
Emily L. Blalock United States	4	138 1.2×	62 0.6×	25 0.8×	33 1.4×	18 1.2×	7	209
Elena M. Cortizas United States	6	74 0.6×	103 0.9×	46 1.5×	23 1.0×	12 0.8×	8	172
Preetha Balasubramanian United States	6	113 0.9×	85 0.8×	15 0.5×	25 1.1×	18 1.2×	8	200
Pablo Pérez‐Durán Spain	5	89 0.7×	153 1.4×	53 1.7×	17 0.7×	56 3.7×	8	242
Nico Trautwein Germany	6	164 1.4×	131 1.2×	77 2.5×	19 0.8×	12 0.8×	8	254
Floriana Cremasco Switzerland	4	181 1.5×	71 0.6×	67 2.2×	21 0.9×	12 0.8×	5	273
Sarah A. E. Galloway United Kingdom	3	158 1.3×	81 0.7×	114 3.7×	23 1.0×	17 1.1×	3	237
Zéliha Oruc France	10	213 1.8×	161 1.4×	18 0.6×	21 0.9×	10 0.7×	16	330
Isabella Fraschilla United States	6	118 1.0×	123 1.1×	38 1.2×	16 0.7×	10 0.7×	8	200
Simone Reinwald Australia	7	187 1.6×	78 0.7×	76 2.5×	13 0.6×	5 0.3×	9	275

Countries citing papers authored by V.K. Chiu

Since Specialization

Citations

This map shows the geographic impact of V.K. Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.K. Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.K. Chiu more than expected).

Fields of papers citing papers by V.K. Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.K. Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.K. Chiu. The network helps show where V.K. Chiu may publish in the future.

Co-authorship network of co-authors of V.K. Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of V.K. Chiu. A scholar is included among the top collaborators of V.K. Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.K. Chiu. V.K. Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Baca, Yasmine, Anthony F. Shields, Anand Prakash, et al.. (2025). Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy. ESMO Open. 10(6). 105315–105315.

Rosenberg, Ari, Shumei Kato, Daniel Johnson, et al.. (2024). 27O Interim results of a phase I/II trial of NT219 in combination with cetuximab in patients with advanced/metastatic squamous cell carcinoma of the head and neck (SCCHN). ESMO Open. 9. 102355–102355.

Khalil, M.F., Michael Rothe, Pam K. Mangat, et al.. (2023). 207P Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. Annals of Oncology. 34. S265–S266. 1 indexed citations

Lakhani, Nehal J., Irene Braña, V.K. Chiu, et al.. (2021). 556TiP A phase I study of SGN-STNV, a novel antibody–drug conjugate targeting sialyl-thomsen-nouveau antigen (STn), in adults with advanced solid tumors (SGNSTNV-001). Annals of Oncology. 32. S613–S614. 1 indexed citations

Klempner, Samuel J., Cynthia A. Sirard, V.K. Chiu, et al.. (2021). 1384P DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial. Annals of Oncology. 32. S1048–S1049. 3 indexed citations

Shah, Manish A., Takayuki Yoshino, Niall C. Tebbutt, et al.. (2021). O-7 FOLFIRI ± napabucasin in patients with previously treated metastatic colorectal cancer: Overall survival results from the phase 3 CanStem303C study. Annals of Oncology. 32. S220–S220. 2 indexed citations

Dragnev, Konstantin H., Taofeek K. Owonikoko, Tibor Csőszi, et al.. (2018). Trilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy. Annals of Oncology. 29. viii597–viii597. 1 indexed citations

Chiu, V.K., et al.. (1995). Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity.. The Journal of Immunology. 154(5). 2023–2032. 96 indexed citations

Walsh, Craig M., Alison A. Glass, V.K. Chiu, & William R. Clark. (1994). The role of the Fas lytic pathway in a perforin-less CTL hybridoma.. The Journal of Immunology. 153(6). 2506–2514. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact